Company Filing History:
Years Active: 2014-2015
Title: Innovations by Elena Bryleva in Alzheimer's Disease Treatment
Introduction
Elena Bryleva is an accomplished inventor based in Lebanon, NH (US). She has made significant contributions to the field of Alzheimer's disease research, holding 2 patents that focus on innovative methods for treating this debilitating condition. Her work aims to improve cognitive function and reduce the impact of amyloid pathology in patients.
Latest Patents
Elena's latest patents include groundbreaking methods for selectively inhibiting Acyl-CoA:Cholesterol Acyltransferase 1 (ACAT1) in the treatment of Alzheimer's disease. The first patent describes methods for stimulating the clearance of amyloid beta in microglia, which is crucial for decreasing cognitive decline associated with amyloid pathology. The second patent focuses on methods for decreasing the size and density of amyloid plaques, further contributing to the treatment of Alzheimer's disease by selectively inhibiting ACAT1 without affecting Acyl-CoA:Cholesterol Acyltransferase 2.
Career Highlights
Elena Bryleva is affiliated with Dartmouth College, where she conducts her research and develops her innovative methods. Her work has garnered attention in the scientific community for its potential to change the landscape of Alzheimer's treatment.
Collaborations
Elena collaborates with esteemed colleagues, including Ta-Yuan Chang and Catherine C Y Chang, who contribute to her research efforts and enhance the impact of her inventions.
Conclusion
Elena Bryleva's contributions to Alzheimer's disease research through her innovative patents highlight her dedication to improving patient outcomes. Her work represents a significant advancement in the fight against cognitive decline and amyloid pathology.